Onconetix, Inc. (ONCO) vs Vivos Therapeutics, Inc. (VVOS)
A side-by-side comparison of Onconetix, Inc. and Vivos Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ONCO
Onconetix, Inc.
$0.66HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VVOS
Vivos Therapeutics, Inc.
$0.15HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ONCO vs VVOS
growth of $100 · dividends reinvested · last 5yONCO -100.0% (-96.3%/yr)VVOS -99.8% (-70.6%/yr)VVOS compounded faster over this window
Log scale — wide-divergence pair
ONCO VVOS
ONCO vs VVOS: by the numbers
- •ONCO is the larger company ($2M vs $2M market cap).
- •Both run net losses; VVOS's is the smaller (-122.42% vs -1578.79% net margin).
Metrics side by side
Valuation
| Metric | ONCO | VVOS |
|---|---|---|
| P/S ratio | 3.67 | 0.10 |
| P/B ratio | 0.18 | N/A |
Profitability
| Metric | ONCO | VVOS |
|---|---|---|
| Gross margin | 80.40% | 59.72% |
| Operating margin | -778.16% | -107.92% |
| Net margin | -1578.79% | -122.42% |
| ROE | -75.70% | N/A |
| ROIC | -59.84% | -182.30% |
Growth (annualized)
| Metric | ONCO | VVOS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 7.52% |
| Total return CAGR (5Y) | N/A | -72.60% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.